You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
ReviveMed's technology uses artificial intelligence-based analysis of metabolomics data for drug discovery and development.
The companies will integrate Agilent's Seahorse XFe96/XFe24 Analyzers with BioTek's Cytation 1 Cell Imaging Multi-Mode Reader.
In PNAS this week: genetic diversity of MERS in African camels, centromere evolution in Cryptococcus, and more.
The companies will offer a system for the identification and quantitation of metabolites in biological samples.
In PLOS this week: metabolite profiles of typhoid fever, shifts in cell-free DNA levels following exercise, and more.
The researchers found multiple enzymes that indicate causes of dysregulated adaptive immunity and tissue damage in fatal Ebola virus disease.
Bioage Labs now intends to set up an internal laboratory to experiment with different compounds, while building out its team.
In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.
Investigators are searching for non-invasive biomarkers of rejection and earlier stage graft injury in children and adults who have received kidney transplants.
Researchers reported on results for more than 100 healthy individuals who were tracked with 'omics and clinical tests over nine months.
Nearly 30,000 COVID-19 tests the UK sent to the US came back as void, according to the Telegraph.
Black principal investigators receive less favorable application scores when seeking US National Institutes of Health grants, the Chronicle of Higher Education reports.
New Scientist reports that both RNA and DNA may have been involved in the emergence of life on Earth.
In Nature this week: new Sperm-seq method enables crossover analysis, tumor-informed detection approach for minimal residual disease, and more.